| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 76 |
| 1 | AZACITIDINE | 62 |
| 2 | AZACITIDINE FOR | 56 |
| 3 | CYTARABINE | 29 |
| 4 | FLUDARABINE PHOSPHATE | 24 |
| 5 | DECITABINE | 19 |
| 6 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 15 |
| 7 | CYCLOPHOSPHAMIDE | 14 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLASDEGIB | 4 | 0.0084 |
| 1 | ECHINACEA (ANGUSTIFOLIA), TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BRYONIA (ALBA), COCCULUS INDICUS, COLCHICUM AUTUMNALE, LEDUM PALUSTRE, MERCURIUS CYANATUS, NATRUM SULPHURICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, AFLATOXIN (B1) | 5 | 0.0071 |
| 2 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 15 | 0.0062 |
| 3 | DECITABINE | 19 | 0.0044 |
| 4 | GILTERITINIB | 13 | 0.0032 |
| 5 | VORINOSTAT | 5 | 0.0023 |
| 6 | CLOFARABINE | 5 | 0.0022 |
| 7 | AZACITIDINE | 62 | 0.0021 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 10 | 0.0016 |
| 9 | QUIZARTINIB | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 100 |
| 1 | BCL-2 Inhibitor [EPC] | 76 |
| 2 | Azole Antifungal [EPC] | 24 |
| 3 | Alkylating Drug [EPC] | 16 |
| 4 | Anthracycline Topoisomerase Inhibitor [EPC] | 15 |
| 5 | Topoisomerase Inhibitor [EPC] | 15 |
| 6 | Corticosteroid [EPC] | 14 |
| 7 | Leukocyte Growth Factor [EPC] | 12 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 9 |
| 9 | Kinase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 15 | 0.0062 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 5 | 0.0013 |
| 2 | BCL-2 Inhibitor [EPC] | 76 | 0.0012 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 4 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 5 | CD33-directed Immunoconjugate [EPC] | 3 | 0.0008 |
| 6 | Actinomycin [EPC] | 1 | 0.0005 |
| 7 | Hedgehog Pathway Inhibitor [EPC] | 4 | 0.0004 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 100 | 0.0004 |
| 9 | Anthelmintic [EPC] | 1 | 0.0003 |